Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Toxicology Investigators Consortium 2022 Annual Report.
Amaducci AM, Campleman SL, Li S, Karshenas DL, Spyres MB, Farrugia LA, Kang AM, Culbreth RE, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Amaducci AM, et al. Among authors: kang am. J Med Toxicol. 2023 Oct;19(4):313-340. doi: 10.1007/s13181-023-00962-2. Epub 2023 Aug 29. J Med Toxicol. 2023. PMID: 37644342
The Toxicology Investigators Consortium Case Registry-the 2021 Annual Report.
Love JS, Karshenas DL, Spyres MB, Farrugia LA, Kang AM, Nguyen H, Campleman SL, Li S, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Love JS, et al. Among authors: kang am. J Med Toxicol. 2022 Oct;18(4):267-296. doi: 10.1007/s13181-022-00910-6. Epub 2022 Sep 7. J Med Toxicol. 2022. PMID: 36070069 Free PMC article.
Correction to: The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report.
Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, Li S, Beauchamp GA, Wiegand T, Wax PM, Brent J; Toxicology Investigators Consortium Study Group. Spyres MB, et al. Among authors: kang am. J Med Toxicol. 2022 Jan;18(1):74. doi: 10.1007/s13181-021-00869-w. J Med Toxicol. 2022. PMID: 34907513 Free PMC article. No abstract available.
Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer.
Sun X, Zhai J, Sun B, Parra ER, Jiang M, Ma W, Wang J, Kang AM, Kannan K, Pandurengan R, Zhang S, Solis LM, Haymaker CL, Raso MG, Mendoza Perez J, Sahin AA, Wistuba II, Yam C, Litton JK, Yang F. Sun X, et al. Among authors: kang am. Mod Pathol. 2022 May;35(5):601-608. doi: 10.1038/s41379-021-00973-w. Epub 2021 Nov 27. Mod Pathol. 2022. PMID: 34839351 Free article.
The Toxicology Investigators Consortium 2020 Annual Report.
Spyres MB, Aldy K, Farrugia LA, Kang AM, Love JS, Campleman SL, Li S, Amaducci A, Schwarz E, Wax PM, Brent J; Toxicology Investigators Consortium Study Group. Spyres MB, et al. Among authors: kang am. J Med Toxicol. 2021 Oct;17(4):333-362. doi: 10.1007/s13181-021-00854-3. Epub 2021 Sep 17. J Med Toxicol. 2021. PMID: 34535889 Free PMC article.
29 results